cetylpyridinium chloride anhydrous and Chronic Hepatitis C

cetylpyridinium chloride anhydrous has been researched along with Chronic Hepatitis C in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cornberg, M; Jelovcan, SB; Jilma, B; Klade, CS; Manns, MP; Schlaphoff, V; Tauber, E; Wedemeyer, H	1

Trials

1 trial(s) available for cetylpyridinium chloride anhydrous and Chronic Hepatitis C

Article	Year
Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients. Vaccine, 2007, Sep-17, Volume: 25, Issue:37-38 Topics: Adolescent; Adult; CD8-Positive T-Lymphocytes; Female; Health; Hepacivirus; Hepatitis C, Chronic; Humans; Immunologic Memory; Male; Middle Aged; Phenotype; Vaccines, Subunit; Viral Hepatitis Vaccines	2007

Article

Year

Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.

Vaccine, 2007, Sep-17, Volume: 25, Issue:37-38

Topics: Adolescent; Adult; CD8-Positive T-Lymphocytes; Female; Health; Hepacivirus; Hepatitis C, Chronic; Humans; Immunologic Memory; Male; Middle Aged; Phenotype; Vaccines, Subunit; Viral Hepatitis Vaccines

2007